FDA
OKs First Embryonic Stem Cell Research Trial On
Humans, Despite Concerns
The
Obama administration has approved the bid by
cloning company Geron to undertake the first
trial involving the use of embryonic stem
cells in humans. They have never been used
before in people because the cells cause
tumors and have been plagued by immune system
rejection issues when tried in animals.
Scientists and pro-life
advocates say human embryonic stem cells are
not ready for trial because problems
associated with the cells in animals haven't
been solved. The
Food and Drug Administration had initially
placed the trial on hold but Geron indicated
today that the agency is now allowing it to
proceed with an early stage trial on a stem
cell therapy for acute spinal cord injury.
The FDA placed a hold on
the trial last August, when evidence showed
Geron's GRNOPC1 encountered safety issues when
used in animal studies. Geron's own data
showed higher frequency of small cysts within
the injury site in the spinal cord of animals
injected with the embryonic cells.